Guoying Wang

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 9

Top Topics

Metastatic Colorectal Cancer

Magnetic Resonance

Clinical Evaluation

Top Venues

Cancer medicine

Journal of hepatocellular carcinoma

Journal of clinical and translational hepatology

Pharmacogenomics and personalized medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Liang Qiao, Wei He, Guoying Wang, Huanwei Chen, Fuxi Huang, Bo Zhang, Yuxiong Qiu, Shaoru Liu, Zhenkun Huang, Yichuan Yuan, Jiliang Qiu, Yichuan Yuan, Bin-Kui Li
Regorafenib with immunotherapy versus regorafenib alone as second-line treatment for hepatocellular carcinoma: A multicenter real-world study. Cancer medicine 13 (9) (2024)
Liang Qiao, Wei He, Guoying Wang, Huanwei Chen, Fuxi Huang, Bo Zhang, Yuxiong Qiu, Shaoru Liu, Zhenkun Huang, Yichuan Yuan, Jiliang Qiu, Yichuan Yuan, Bin-Kui Li
Regorafenib with immunotherapy versus regorafenib alone as second-line treatment for hepatocellular carcinoma: A multicenter real-world study. Cancer medicine 13 (9) (2024)
Liang Qiao, Wei He, Guoying Wang, Huanwei Chen, Fuxi Huang, Bo Zhang, Yuxiong Qiu, Shaoru Liu, Zhenkun Huang, Yichuan Yuan, Jiliang Qiu, Yichuan Yuan, Bin-Kui Li
Regorafenib with immunotherapy versus regorafenib alone as second-line treatment for hepatocellular carcinoma: A multicenter real-world study. Cancer medicine 13 (9) (2024)
Liang Qiao, Wei He, Guoying Wang, Huanwei Chen, Fuxi Huang, Bo Zhang, Yuxiong Qiu, Shaoru Liu, Zhenkun Huang, Yichuan Yuan, Jiliang Qiu, Yichuan Yuan, Bin-Kui Li
Regorafenib with immunotherapy versus regorafenib alone as second-line treatment for hepatocellular carcinoma: A multicenter real-world study. Cancer medicine 13 (9) (2024)
Tianxing Dai, Jing Li, Run-Bin Liang, Haoyuan Yu, Xu Lu, Guoying Wang
Identification and Experimental Validation of the Prognostic Significance and Immunological Correlation of Glycosylation-Related Signature and ST6GALNAC4 in Hepatocellular Carcinoma. Journal of hepatocellular carcinoma 10 (2023)
Tianxing Dai, Linsen Ye, Mingbin Deng, Guozhen Lin, Rongqiang Liu, Haoyuan Yu, Wei Liu, Yang Yang, Guoying Wang
Upregulation of TMCO3 Promoting Tumor Progression and Contributing to the Poor Prognosis of Hepatocellular Carcinoma. Journal of clinical and translational hepatology 10 (5) (2022)
Tianxing Dai, Linsen Ye, Haoyuan Yu, Kun Li, Jing Li, Rong-Qiang Liu, Xu Lu, Mingbin Deng, Rong Li, Wei Liu, Yang Yang, Guoying Wang
Regulation Network and Prognostic Significance of Aldo-Keto Reductase (AKR) Superfamily Genes in Hepatocellular Carcinoma. Journal of hepatocellular carcinoma 8 (2021)
Tianxing Dai, Jing Li, Linsen Ye, Haoyuan Yu, Mingbin Deng, Wei Liu, Hua Li, Yang Yang, Guoying Wang
Prognostic Role and Potential Mechanisms of N6-methyladenosine-related Long Noncoding RNAs in Hepatocellular Carcinoma. Journal of clinical and translational hepatology 10 (2) (2021)
Tianxing Dai, Jing Li, Xu Lu, Linsen Ye, Haoyuan Yu, Lele Zhang, Mingbin Deng, Shuguang Zhu, Wei Liu, Guoying Wang, Yang Yang
Prognostic Role and Potential Mechanisms of the Ferroptosis-Related Metabolic Gene Signature in Hepatocellular Carcinoma. Pharmacogenomics and personalized medicine 14 (2021)